跳至主要内容
临床试验/NCT01446432
NCT01446432Unknown不适用

A Prospective Study to Validate Two New Patient Reported Outcome Measures for Dupuytren's Disease in Patients Treated With XIAFLEX

Robert Hotchkiss1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
1
主要终点
QuickDASH (Disability of the Arm, Shoulder, and Hand)

研究概览

简要总结

A study to validate two newly developed questionnaires for Dupuytren's Disease. The objective is to develop a patient specific outcomes tool for Dupuytren's Disease. While there are standard and validated questionnaire instruments used to measure health related quality of life and function, they do not address patient specific issues. The investigators will also pilot a treatment/disease specific satisfaction questionnaire for Xiaflex use for Dupuytren's Disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has a diagnosis of Dupuytren's Disease in at least one finger
  • Patients will be 35 years of age or older
  • Patients will be able to read, speak, and understand English
  • Patients will be able to provide voluntary written consent to participate

排除标准

  • Female patients who are nursing or pregnant, or plan to become pregnant during the treatment phase.
  • Patient has a chronic muscular, neurological or neuromuscular disorder that affects the hands.
  • Patient has a known allergy to collagenase or any other excipient of XIAFLEX.
  • Patient has received any collagenase treatments before the first dose of XIAFLEX.
  • Any history of or current medical condition which in the investigator's opinion would make the subject unsuitable for enrollment in the study

结局指标

主要结局

QuickDASH (Disability of the Arm, Shoulder, and Hand)

时间窗: 30 day follow up

次要结局

未报告次要终点

研究者

发起方
Robert Hotchkiss
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Robert Hotchkiss

MD

Hospital for Special Surgery, New York

研究点 (1)

Loading locations...

相似试验

Validation of Two New Questionnaires for Dupuytren's... | 临床试验